EPISODE · Apr 30, 2026 · 6 MIN
What To Expect After China’s First siRNA Firm Went Public
from Citeline Podcasts · host Norstella
In this episode of the China biopharma English-language podcast, Xu Hu talks about the siRNA area, including possible industry and R&D environment changes for Chinese firms developing these therapies and trends in deals of China-originated siRNA assets this year. Story link: Chinese siRNA Contenders Set For Transitions, Deals In 2026
Embed this episode
NOW PLAYING
What To Expect After China’s First siRNA Firm Went Public
0:00
6:45
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Citeline Podcasts?
This episode is 6 minutes long.
When was this Citeline Podcasts episode published?
This episode was published on April 30, 2026.
Can I download this Citeline Podcasts episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!